Ven una gran reducción en las admisiones para el tratamiento de la adicción a las drogas durante la pandemia
LUNES, 26 de septiembre de 2022 (HealthDay News) — Las admisiones a los programas de tratamiento para la adicción a las drogas se redujeron durante el primer año de la pandemia, lo que es probable que explica un aumento posterior en las sobredosis le…
Learn MoreIr en bicicleta drogados con metanfetamina y opioides envía a miles a emergencias
LUNES, 26 de septiembre de 2022 (HealthDay News) — Ir en bicicleta mientras se está drogado conduce a miles de accidentes graves cada año, sugiere un estudio reciente.Tan solo entre 2019 y 2020, más de 11,000 personas fueron tratadas en las salas de …
Learn MoreUSPSTF Recommends Syphilis Screening for At-Risk Persons
TUEDAY, Sept. 27, 2022 (HealthDay News) — The U.S. Preventive Services Task Force (USPSTF) recommends syphilis screening for asymptomatic, nonpregnant adolescents and adults who have ever been sexually active and are at increased risk for infection. …
Learn MoreRace-Free Creatinine Equation May Cut Disparity in Kidney Wait Time
TUESDAY, Sept. 27, 2022 (HealthDay News) — Use of the creatinine race-free 2021 Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation to determine eligibility for the kidney transplant wait list may reduce racial differences in preempt…
Learn MoreApixaban Noninferior to Enoxaparin for Postoperative VTE Prophylaxis
TUESDAY, Sept. 27, 2022 (HealthDay News) — Apixaban is noninferior to enoxaparin for extended-duration venous thromboembolic event prophylaxis (EP) after abdominopelvic oncologic surgery, according to a study published in the October issue of The Jou…
Learn MoreSemaglutide Reduces 10-Year Risk for T2D in Obese Persons
TUESDAY, Sept. 27, 2022 (HealthDay News) — Semaglutide reduces the 10-year risk for type 2 diabetes (T2D) in obese or overweight individuals, and sustained treatment is needed to maintain this risk reduction, according to a study presented at the ann…
Learn MoreTriplet Therapy Ups Progression-Free Survival in Advanced Kidney Cancer
MONDAY, Sept. 26, 2022 (HealthDay News) — Triplet therapy of cabozantinib + nivolumab + ipilimumab significantly improves progression-free survival (PFS) compared with placebo + nivolumab + ipilimumab for patients with previously untreated advanced r…
Learn MoreClinic Brings Free Health Care to Homeless Youth — and Their Beloved Pets
TUESDAY, Sept. 27, 2022 (HealthDay News) — Five years back, “Nugget” the Jack-A-Poo was in serious need of some tender loving veterinary care.“He needed vaccinations and a few other things,” Seattle native Grace Stroklund recalled of her sidekick, a …
Learn MoreOver-the-Counter Hearing Aids Are Coming in October. Experts Offer Tips for Consumers
TUESDAY, Sept. 27, 2022 (HealthDay News) — Adults with hearing loss soon will be able to amble into a big box store or pharmacy — or just visit a website — and buy hearing aids without a prescription.Over-the-counter hearing aids will be on the marke…
Learn MoreSpikes in Blood Pressure Bring Many Americans to the ER
TUESDAY, Sept. 27, 2022 (HealthDay News) — When it comes to why U.S. heart patients wind up in the emergency room, uncontrolled high blood pressure (or “hypertension”) fuels about one-third of those medical crises.“These visits resulted in hospital a…
Learn More